Navigation Links
Transdel Pharmaceuticals, Inc. Retains FLP Pharma to Lead Business Development Activities
Date:2/2/2009

LA JOLLA, Calif., Feb. 2 /PRNewswire-FirstCall/ -- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP) (http://www.transdelpharma.com), a specialty pharmaceutical company focused on developing and commercializing non-invasive, topically administered medications, has retained FLP Pharma, a Georgia-based pharmaceutical consultancy, to lead its business development activities, especially the out-licensing of its lead product Ketotransdel(R). FLP Pharma has an experienced track record in negotiating and closing global and regional joint development, licensing, distribution, sales and marketing partnerships and supply agreements with multiple pharmaceutical companies.

"Our Phase 3 clinical trial of Ketotransdel(R) continues to advance," stated Dr. Juliet Singh, President and CEO of Transdel Pharmaceuticals. "We also continue to explore co-development opportunities in other therapeutic areas utilizing our Transdel(TM) platform technology. With the addition of FLP Pharma and its successful track record, we expect to significantly advance our partnering efforts especially for our lead pain product Ketotransdel(R) and achieve a significant milestone in our growth as a specialty pharmaceutical company."

"Transdel has implemented a focused approach in negotiating with pharmaceutical companies with a strategic interest in pain management and the requisite infrastructure to successfully commercialize Ketotransdel(R)," stated Terry Nida, Principal of FLP Pharma. "We are open to partnering with pharmaceutical companies with either a global or regional capacity to help us achieve our corporate goals."

The Company is also investigating other novel and generic drugs and promising therapeutic areas in combination with using their patented transdermal delivery system. Furthermore, the Company recently announced that they are expanding their product development pr
'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Transdel Expands Program to Include Cosmetic/Cosmeceutical Products
2. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
3. Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference
4. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
5. Genesis Pharmaceuticals Enters Into Agreement to Purchase Hongrui Pharmaceuticals, and Acquire 22 New Traditional Chinese Medicines
6. Renhuang Pharmaceuticals, Inc. Engages New Independent Auditor
7. Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements
8. Amira Pharmaceuticals, Inc. Expands its Scientific Advisory Board and Appoints Dr. Paul Anderson, Professor Jerold Chun and Professor Andrew Tager
9. Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.
10. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2014)... CEDR HR Solutions , a ... of customized medical and dental employee handbooks, has announced ... fall. CEDR’s CEO will be featured as a speaker ... , From September 4-6, CEDR will attend the 10th ... Managers Conference in San Diego, to be held at ...
(Date:8/1/2014)... (PRWEB) August 02, 2014 Recently, iFitDress.com, one ... unveiled its new assortment of top bridesmaid dresses ... provided at promotional prices, up to 52% off. According to ... the middle of August. , The company’s stock is ... should visit its online store as soon as possible. All ...
(Date:8/1/2014)... University School of Medicine in St. Louis helps explain ... frequently are more harmful than similar tumors in females. ... are diagnosed twice as often in males, who suffer ... as long. , The researchers found that retinoblastoma protein ... significantly less active in male brain cells than in ...
(Date:8/1/2014)... York, New York (PRWEB) August 01, 2014 ... filed in the wake of the 2012 Rejuvenate ... to move forward in New Jersey’s Bergen County ... documents filed in the proceeding, the Court has ... of Confidentiality governing any and all hard copy ...
(Date:8/1/2014)... 2014 As it continues to investigate ... who allegedly experienced the spread of uterine cancers due ... Bernstein Liebhard LLP notes the growing reaction to Johnson ... morcellators marketed by its Ethicon, Inc. unit from the ... Times, some critics of the company said they were ...
Breaking Medicine News(10 mins):Health News:Nuanced Media Client, CEDR HR Solutions, to Speak at Upcoming Major Dental Conferences 2Health News:Nuanced Media Client, CEDR HR Solutions, to Speak at Upcoming Major Dental Conferences 3Health News:iFitDress.com: Top Bridesmaid Dresses For The Global Customers 2Health News:Study reveals one reason brain tumors are more common in men 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4
... than 500 Workers, WASHINGTON, May 16 ... the Greater Portland, Oregon and,Vancouver, Washington area have ... are pleased that these workers are now covered ... and a secure retirement,future," said Teamsters General President ...
... fibroids located just beneath the lining of the uterus (submucosal) ... uterine artery embolization (UAE) but usually dont cause major complications, ... 49 patients with 140 fibroids who underwent an MRI examination ... these were submucosal. Of these, 33% migrated to the endometrial ...
... Kwon Presents Urban Health Institute with 10,000 Sensual O Condom ... Mansion Fundraiser, LOS ANGELES, May 16 On Saturday, ... known best for his hit song "Everybody in the Club,Gettin, ... Sensual O Vibrating Condom Packs worth over $50,000. The donation ...
... May 16 Huntsworth plc (LSE: HNT), "the Group",a leading international public relations and healthcare ... the first quarter 2008 (the period,ending March 31, 2008)., The statement follows below., ... ... Interim Management Statement, ...
... Nationwide,Health Properties, Inc. (NYSE: NHP ) announced ... Vice President and Senior Investment Officer. "Dave,has made ... several years as,evidenced by our strong investment growth ... over $1 billion in accretive,investments for NHP, leveraging ...
... for at least a year or two, , , FRIDAY, ... people with type 1 diabetes live insulin-free for at ... longer-term improved metabolic control even after people have to ... glucose monitoring systems, researchers from the University of Miami ...
Cached Medicine News:Health News:Everybody in the Club Scream O! 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 2Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 3Health News:Huntsworth plc Releases Interim Statement on First Quarter 2008 4Health News:David M. Boitano Promoted to Senior Vice President 2Health News:Islet Cell Transplants Aid Type 1 Diabetics 2Health News:Islet Cell Transplants Aid Type 1 Diabetics 3
(Date:8/1/2014)... , Aug. 1, 2014  Neuland Laboratories ... active pharmaceutical ingredients (APIs), complex intermediates ... located in 85 countries, today announced financial results ... 2015, ended June 30, 2014. "Neuland,s ... work flow re-prioritization to accommodate certain customer needs, ...
(Date:8/1/2014)... 1, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 Deep ... Industry" and "2014 Deep Research Report on Global ... its research database. Photo - ... Research Report on Global and China Potassium Nitrate ... on China and Global ...
(Date:7/31/2014)... 2014 STAAR Surgical Company (NASDAQ: ... implantable lenses and delivery systems for the eye today ... 2014 of $20.0 million, a 10% increase over $18.2 ... a constant currency basis, revenues grew 11% during the ... of 2013.  The effect of foreign currency exchange reduced ...
Breaking Medicine Technology:Neuland Labs Reports First Quarter Fiscal Year 2015 Financial Results 2Neuland Labs Reports First Quarter Fiscal Year 2015 Financial Results 3Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 2Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 3Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 4Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30
... ADA,s 2009 Convention -- When Shawnae Jebbia won the Miss ... fairytale career. She appeared at events throughout the world, worked ... Shawnae,s world unexpectedly changed when she was diagnosed with hearing ... she had a difficult time understanding and accepting the sudden ...
... Oct. 29 Mettler-Toledo International Inc. (NYSE: MTD ) today announced ... , Sales in local currency declined by 12% in ... negative currency impact. , Net earnings per diluted ... third quarter of 2008. Adjusted EPS was $1.36, a 6% ...
Cached Medicine Technology:Former Miss USA Shawnae Jebbia Shines with Siemens Pure 2Former Miss USA Shawnae Jebbia Shines with Siemens Pure 3Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 2Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 3Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 4Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 5Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 6Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 7Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 8Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 9Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 10Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 11Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 12Mettler-Toledo International Inc. Reports Third Quarter 2009 Results 13
Scleral blades designed for trabeculectomy and groove type incisions, scleral standard USA size....
Fechtner Trabeculectomy Marker...
... for Nystagmus when rotated at 8-10 ... 8" diameter. Light weight drum of ... effortless spin mechanism. For use 24 ... both Adult and Pediatric Drums that ...
Sterile squares of smooth foil for repair of the floor of the orbit and other plastic surgery. Available in large size....
Medicine Products: